159 related articles for article (PubMed ID: 27147056)
1. Visualization of Genomic Loci in Living Cells with a Fluorescent CRISPR/Cas9 System.
Anton T; Leonhardt H; Markaki Y
Methods Mol Biol; 2016; 1411():407-17. PubMed ID: 27147056
[TBL] [Abstract][Full Text] [Related]
2. CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells.
Deng W; Shi X; Tjian R; Lionnet T; Singer RH
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11870-5. PubMed ID: 26324940
[TBL] [Abstract][Full Text] [Related]
3. Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system.
Anton T; Bultmann S; Leonhardt H; Markaki Y
Nucleus; 2014; 5(2):163-72. PubMed ID: 24637835
[TBL] [Abstract][Full Text] [Related]
4. Customized optical mapping by CRISPR-Cas9 mediated DNA labeling with multiple sgRNAs.
Abid HZ; Young E; McCaffrey J; Raseley K; Varapula D; Wang HY; Piazza D; Mell J; Xiao M
Nucleic Acids Res; 2021 Jan; 49(2):e8. PubMed ID: 33231685
[TBL] [Abstract][Full Text] [Related]
5. Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira.
Fernandes LGV; Guaman LP; Vasconcellos SA; Heinemann MB; Picardeau M; Nascimento ALTO
Sci Rep; 2019 Feb; 9(1):1839. PubMed ID: 30755626
[TBL] [Abstract][Full Text] [Related]
6. Imaging genomic elements in living cells using CRISPR/Cas9.
Chen B; Huang B
Methods Enzymol; 2014; 546():337-54. PubMed ID: 25398348
[TBL] [Abstract][Full Text] [Related]
7. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
[TBL] [Abstract][Full Text] [Related]
8. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
Prykhozhij SV; Rajan V; Gaston D; Berman JN
PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
[TBL] [Abstract][Full Text] [Related]
9. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
[TBL] [Abstract][Full Text] [Related]
10. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
Sakuma T; Sakamoto T; Yamamoto T
Methods Mol Biol; 2017; 1498():41-56. PubMed ID: 27709568
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
Markus BM; Boydston EA; Lourido S
mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
[TBL] [Abstract][Full Text] [Related]
12. Overview of advances in CRISPR/deadCas9 technology and its applications in human diseases.
Kanafi MM; Tavallaei M
Gene; 2022 Jul; 830():146518. PubMed ID: 35447246
[TBL] [Abstract][Full Text] [Related]
13. Simple and versatile imaging of genomic loci in live mammalian cells and early pre-implantation embryos using CAS-LiveFISH.
Geng Y; Pertsinidis A
Sci Rep; 2021 Jun; 11(1):12220. PubMed ID: 34108610
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Regulation with CRISPR/Cas9 Effectors in Mammalian Cells.
Pham H; Kearns NA; Maehr R
Methods Mol Biol; 2016; 1358():43-57. PubMed ID: 26463376
[TBL] [Abstract][Full Text] [Related]
15. Targeted knock-in into the OVA locus of chicken cells using CRISPR/Cas9 system with homology-independent targeted integration.
Shi M; Kawabe Y; Ito A; Kamihira M
J Biosci Bioeng; 2020 Mar; 129(3):363-370. PubMed ID: 31594694
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.
Wu X; Scott DA; Kriz AJ; Chiu AC; Hsu PD; Dadon DB; Cheng AW; Trevino AE; Konermann S; Chen S; Jaenisch R; Zhang F; Sharp PA
Nat Biotechnol; 2014 Jul; 32(7):670-6. PubMed ID: 24752079
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
Goubert D; Koncz M; Kiss A; Rots MG
Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
[TBL] [Abstract][Full Text] [Related]
19. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
Peng R; Lin G; Li J
FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease.
Kuscu C; Arslan S; Singh R; Thorpe J; Adli M
Nat Biotechnol; 2014 Jul; 32(7):677-83. PubMed ID: 24837660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
